Tirzepatide vs Retatrutide in Canada: Which One Wins?

Written by

in

By Judith Wenshuk, peptide research writer

Quick Answer: Retatrutide‘s triple-receptor mechanism has produced stronger trial results than Tirzepatide‘s dual-receptor mechanism — up to 28.7% weight loss versus 20–22% — but Tirzepatide has a longer, more established research and real-world track record. The “winner” depends on whether trial results or research maturity matters more for your purposes.

These are the two most directly comparable compounds in the GLP-1 family right now, both available through research peptide suppliers in Canada, and the comparison genuinely comes down to a tradeoff rather than a clear winner.

Mechanism

Tirzepatide activates two receptors (GLP-1 and GIP). Retatrutide activates three (GLP-1, GIP, and glucagon). The additional glucagon receptor activity in Retatrutide is believed to be responsible for its stronger trial results, including its distinctive liver-fat-reduction findings that Tirzepatide’s trials haven’t shown to the same degree.

Trial Results

  • Tirzepatide: 20–22% average weight loss (SURMOUNT-1, 72 weeks)
  • Retatrutide: 24.2% at 48 weeks (Phase 2), up to 28.7% in later Phase 3 data (TRIUMPH)

Research Maturity

Tirzepatide has a longer trial history and more accumulated real-world data. Retatrutide’s results are stronger but come from a newer, less-established research program — a genuine tradeoff between proven track record and stronger headline numbers.

Escalation and Tolerability

Both use a similar four-phase gradual escalation pattern. Reported side effects during escalation are broadly similar between the two — primarily nausea and appetite changes — though this varies significantly by individual regardless of which compound is used.

Frequently Asked Questions

Is Retatrutide simply a stronger version of Tirzepatide? Not exactly — it’s a distinct compound with an additional receptor mechanism, which is what drives its stronger trial results rather than a higher dose of the same mechanism.

Are both available in Canada? Yes — both Tirzepatide and Retatrutide are available through research peptide suppliers in Canada.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *